A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma.
Vergote IB, Smith DC, Berger R, Kurzrock R, Vogelzang NJ, Sella A, Wheler J, Lee Y, Foster PG, Weitzman R, Buckanovich RJ.
Vergote IB, et al. Among authors: smith dc.
Eur J Cancer. 2017 Sep;83:229-236. doi: 10.1016/j.ejca.2017.06.018. Epub 2017 Jul 26.
Eur J Cancer. 2017.
PMID: 28755607
Free article.
Clinical Trial.